Arcutis Biotherapeutics Inc (ARQT) Volatility Spurs A Quest For Clarity
Suvretta Capital Management LLC recently announced the acquisition of new stake in Arcutis Biotherapeutics Inc (NASDAQ:ARQT). The institutional investor has increased its shareholding in the Healthcare company by 744.96% to 9.59 million shares with purchase of 8.46 million shares. This fresh investment now brings its stake to 10.16% valued currently at $17.65 million. In addition, […]
